  Breast cancer is the most common cancer among women worldwide. The human
epidermal growth factor receptor 2 (HER2) with immunohistochemical (IHC) is
widely used for pathological evaluation to provide the appropriate therapy for
patients with breast cancer. However, the deficiency of pathologists and
subjective and susceptible to inter-observer variation of visual diagnosis are
the main challenges. Recently, with the rapid development of artificial
intelligence (AI) in disease diagnosis, several automated HER2 scoring methods
using traditional computer vision or machine learning methods indicate the
improvement of the HER2 diagnostic accuracy, but the unreasonable
interpretation in pathology, as well as the expensive and ethical issues for
annotation, make these methods still have a long way to deploy in hospitals to
ease pathologists' burden in real. In this paper, we propose a HER2 automated
scoring system that strictly follows the HER2 scoring guidelines simulating the
real workflow of HER2 scores diagnosis by pathologists. Unlike the previous
work, our method considers the positive control of HER2 to make sure the assay
performance for each slide, eliminating work for repeated comparison between
the current field of view (FOV) and positive control FOV, especially for the
borderline cases. Besides, for each selected FOV under the microscope, our
system provides real-time HER2 scores analysis and visualizations of the
membrane staining intensity and completeness corresponding with the cell
classifications. Our rigorous workflow along with the flexible interactive
adjustion in demand substantially assists pathologists to finish the HER2
diagnosis faster and improves the robustness and accuracy. The proposed system
will be embedded in our Thorough Eye platform for deployment in hospitals.
